Log In
BCIQ
Print this Print this
 

Omiralin

  Manage Alerts
Collapse Summary General Information
Company Microlin Bio Inc.
DescriptionAnti-microRNA-484 (miR-484)
Molecular Target MicroRNA-484 (miR-484)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: microRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today